BridgeMD
New treatment option for Apathy
Official title Multidimensional Apathy in Psychiatric Pathologies.
ClinicalTrials.gov ID: NCT04757220
What this study is testing
- What it's testing
- Apathy is defined by quantitative decrease in goal-directed activity in comparison to the person's previous level of functioning. Apathy is a transnosographic symptom, prevalent in many neurological and psychiatric pathologies (specifically in schizophrenia and depression), and almost half of patients suffer from it.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60. Healthy volunteers may be eligible.
You may be able to join if
- (all people):
- age between 18 and 60 years
- men or women volunteers, hospitalized or not
- subject affiliated to an health insurance
- subject having signed an informed consent (for schizophrenic patients): \- presence of DSM-V TR criteria for schizophrenia (American Psychiatric...
You likely can't join if
- a major or non stabilized somatic disorder
- medical history likely to affect cerebral anatomy or linked to an abnormality (neonatal distress, neurochirurgical intervention, neurological...
- any disorders involved in the use of a psycho-active substance (as defined by the DSM-IV)
- sensory disabling impairments, and specifically visual acuity \< 8
- general anaesthesia during the 3 months before the study
- pregnancy (declared by the subject)
See the full eligibility criteria
- (all people):
- age between 18 and 60 years
- men or women volunteers, hospitalized or not
- subject affiliated to an health insurance
- subject having signed an informed consent (for schizophrenic patients): \- presence of DSM-V TR criteria for schizophrenia (American Psychiatric Association, 1994) (for depressive patients): \- presence of DSM-V TR...
- a major or non stabilized somatic disorder
- medical history likely to affect cerebral anatomy or linked to an abnormality (neonatal distress, neurochirurgical intervention, neurological disorders, stroke attack)
- any disorders involved in the use of a psycho-active substance (as defined by the DSM-IV)
- sensory disabling impairments, and specifically visual acuity \< 8
- general anaesthesia during the 3 months before the study
- pregnancy (declared by the subject)
- persons in an emergency situation
- persons deprived in any way of their liberty
- persons in period of exclusion in an other protocol Exclusion criteria (for controls): \- use of psychotropic substance during the 3 weeks before the study Exclusion criteria (for patients): \- use of benzodiazepines
The study team makes the final eligibility decision.
Where it's taking place
- Strasbourg, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Strasbourg, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.